{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:02:04Z","timestamp":1791295324674,"version":"4.1.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T00:00:00Z","timestamp":1384128000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1038\/ijo.2013.205","type":"journal-article","created":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T08:37:44Z","timestamp":1384159064000},"page":"325-333","source":"Crossref","is-referenced-by-count":55,"title":["Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery?"],"prefix":"10.1038","volume":"38","author":[{"given":"A D","family":"Miras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C W","family":"le Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,11]]},"reference":[{"key":"BFijo2013205_CR1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.giec.2011.02.001","volume":"21","author":"DE Azagury","year":"2011","unstructured":"Azagury DE, Lautz DB . Obesity overview: epidemiology, health and financial impact, and guidelines for qualification for surgical therapy. Gastrointest Endosc Clin N Am 2011; 21: 189\u2013201.","journal-title":"Gastrointest Endosc Clin N Am"},{"issue":"Suppl 1","key":"BFijo2013205_CR2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1467-789X.2007.00311.x","volume":"8","author":"P Kopelman","year":"2007","unstructured":"Kopelman P . Health risks associated with overweight and obesity. Obes Rev 2007; 8 (Suppl 1): 13\u201317.","journal-title":"Obes Rev"},{"key":"BFijo2013205_CR3","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1056\/NEJMoa066254","volume":"357","author":"L Sjostrom","year":"2007","unstructured":"Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741\u2013752.","journal-title":"N Engl J Med"},{"key":"BFijo2013205_CR4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2011.1914","volume":"307","author":"L Sjostrom","year":"2012","unstructured":"Sjostrom L, Peltonen M, Jacobson P, Sjostrom CD, Karason K, Wedel H et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012; 307: 56\u201365.","journal-title":"JAMA"},{"key":"BFijo2013205_CR5","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa1200111","volume":"366","author":"G Mingrone","year":"2012","unstructured":"Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012; 366: 1577\u20131585.","journal-title":"N Engl J Med"},{"key":"BFijo2013205_CR6","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa1200225","volume":"366","author":"PR Schauer","year":"2012","unstructured":"Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366: 1567\u20131576.","journal-title":"N Engl J Med"},{"key":"BFijo2013205_CR7","first-page":"316","volume":"299","author":"JB Dixon","year":"2008","unstructured":"Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008; 299: 316\u2013323.","journal-title":"JAMA"},{"key":"BFijo2013205_CR8","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1001\/jama.2013.5835","volume":"309","author":"S Ikramuddin","year":"2013","unstructured":"Ikramuddin S, Korner J, Lee WJ, Connett JE, Inabnet WB, Billington CJ et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA 2013; 309: 2240\u20132249.","journal-title":"JAMA"},{"key":"BFijo2013205_CR9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1381\/096089203765887679","volume":"13","author":"T Olbers","year":"2003","unstructured":"Olbers T, Lonroth H, Fagevik-Olsen M, Lundell L . Laparoscopic gastric bypass: development of technique, respiratory function, and long-term outcome. Obes Surg 2003; 13: 364\u2013370.","journal-title":"Obes Surg"},{"key":"BFijo2013205_CR10","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1001\/jama.292.14.1724","volume":"292","author":"H Buchwald","year":"2004","unstructured":"Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724\u20131737.","journal-title":"JAMA"},{"key":"BFijo2013205_CR11","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1381\/096089206778026316","volume":"16","author":"PE O'Brien","year":"2006","unstructured":"O'Brien PE, McPhail T, Chaston TB, Dixon JB . Systematic review of medium-term weight loss after bariatric operations. Obes Surg 2006; 16: 1032\u20131040.","journal-title":"Obes Surg"},{"key":"BFijo2013205_CR12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.soard.2009.05.011","volume":"5","author":"SA Brethauer","year":"2009","unstructured":"Brethauer SA, Hammel JP, Schauer PR . Systematic review of sleeve gastrectomy as staging and primary bariatric procedure. Surg Obes Relat Dis 2009; 5: 469\u2013475.","journal-title":"Surg Obes Relat Dis"},{"key":"BFijo2013205_CR13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(09)70159-7","volume":"10","author":"L Sjostrom","year":"2009","unstructured":"Sjostrom L, Gummesson A, Sjostrom CD, Narbro K, Peltonen M, Wedel H et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol 2009; 10: 653\u2013662.","journal-title":"Lancet Oncol"},{"key":"BFijo2013205_CR14","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.2337\/dc11-2353","volume":"35","author":"AD Miras","year":"2012","unstructured":"Miras AD, Chuah LL, Lascaratos G, Faruq S, Mohite AA, Shah PR et al. Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes mellitus. Diabetes Care 2012; 35: e81.","journal-title":"Diabetes Care"},{"key":"BFijo2013205_CR15","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/2012.jama.11580","volume":"308","author":"JB Dixon","year":"2012","unstructured":"Dixon JB, Schachter LM, O'Brien PE, Jones K, Grima M, Lambert G et al. Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA 2012; 308: 1142\u20131149.","journal-title":"JAMA"},{"key":"BFijo2013205_CR16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1530\/EJE-07-0145","volume":"158","author":"MJ Bult","year":"2008","unstructured":"Bult MJ, van Dalen T, Muller AF . Surgical treatment of obesity. Eur J Endocrinol 2008; 158: 135\u2013145.","journal-title":"Eur J Endocrinol"},{"key":"BFijo2013205_CR17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJMoa0901836","volume":"361","author":"DR Flum","year":"2009","unstructured":"Longitudinal Assessment of Bariatric Surgery (LABS) Consortium Flum DR, Belle SH, King WC, Wahed AS, Berk P et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009; 361: 445\u2013454.","journal-title":"N Engl J Med"},{"key":"BFijo2013205_CR18","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nrendo.2012.48","volume":"8","author":"BS Bal","year":"2012","unstructured":"Bal BS, Finelli FC, Shope TR, Koch TR . Nutritional deficiencies after bariatric surgery. Nat Rev Endocrinol 2012; 8: 544\u2013556.","journal-title":"Nat Rev Endocrinol"},{"key":"BFijo2013205_CR19","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s00125-010-1798-5","volume":"53","author":"R Marsk","year":"2010","unstructured":"Marsk R, Jonas E, Rasmussen F, Naslund E . Nationwide cohort study of post-gastric bypass hypoglycaemia including 5040 patients undergoing surgery for obesity in 1986\u20132006 in Sweden. Diabetologia 2010; 53: 2307\u20132311.","journal-title":"Diabetologia"},{"key":"BFijo2013205_CR20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.sla.0000183349.16877.84","volume":"243","author":"CW le Roux","year":"2006","unstructured":"le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006; 243: 108\u2013114.","journal-title":"Ann Surg"},{"key":"BFijo2013205_CR21","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1053\/j.gastro.2009.11.012","volume":"138","author":"M Bueter","year":"2010","unstructured":"Bueter M, Lowenstein C, Olbers T, Wang M, Cluny NL, Bloom SR et al. Gastric bypass increases energy expenditure in rats. Gastroenterology 2010; 138: 1845\u20131853.","journal-title":"Gastroenterology"},{"key":"BFijo2013205_CR22","doi-asserted-by":"crossref","first-page":"e60280","DOI":"10.1371\/journal.pone.0060280","volume":"8","author":"M Werling","year":"2013","unstructured":"Werling M, Olbers T, Fandriks L, Bueter M, Lonroth H, Stenlof K et al. Increased postprandial energy expenditure may explain superior long term weight loss after Roux-en-Y gastric bypass compared to vertical banded gastroplasty. PLoS One 2013; 8: e60280.","journal-title":"PLoS One"},{"key":"BFijo2013205_CR23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.physbeh.2012.02.013","volume":"107","author":"CM Mathes","year":"2012","unstructured":"Mathes CM, Spector AC . Food selection and taste changes in humans after Roux-en-Y gastric bypass surgery: a direct-measures approach. Physiol Behav 2012; 107: 476\u2013483.","journal-title":"Physiol Behav"},{"key":"BFijo2013205_CR24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3945\/ajcn.112.036921","volume":"96","author":"AD Miras","year":"2012","unstructured":"Miras AD, Jackson RN, Jackson SN, Goldstone AP, Olbers T, Hackenberg T et al. Gastric bypass surgery for obesity decreases the reward value of a sweet-fat stimulus as assessed in a progressive ratio task. Am J Clin Nutr 2012; 96: 467\u2013473.","journal-title":"Am J Clin Nutr"},{"key":"BFijo2013205_CR25","doi-asserted-by":"crossref","first-page":"R1057","DOI":"10.1152\/ajpregu.00139.2011","volume":"301","author":"CW le Roux","year":"2011","unstructured":"le Roux CW, Bueter M, Theis N, Werling M, Ashrafian H, Lowenstein C et al. Gastric bypass reduces fat intake and preference. Am J Physiol Regul Integr Comp Physiol 2011; 301: R1057\u2013R1066.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFijo2013205_CR26","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3945\/ajcn.2010.29870","volume":"92","author":"EA Odstrcil","year":"2010","unstructured":"Odstrcil EA, Martinez JG, Santa Ana CA, Xue B, Schneider RE, Steffer KJ et al. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am J Clin Nutr 2010; 92: 704\u2013713.","journal-title":"Am J Clin Nutr"},{"key":"BFijo2013205_CR27","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s11695-012-0656-6","volume":"22","author":"G Wang","year":"2012","unstructured":"Wang G, Agenor K, Pizot J, Kotler DP, Harel Y, Van Der Schueren BJ et al. Accelerated gastric emptying but no carbohydrate malabsorption 1 year after gastric bypass surgery (GBP). Obes Surg 2012; 22: 1263\u20131267.","journal-title":"Obes Surg"},{"key":"BFijo2013205_CR28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/SLA.0b013e318156f012","volume":"247","author":"SN Karamanakos","year":"2008","unstructured":"Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK . Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 2008; 247: 401\u2013407.","journal-title":"Ann Surg"},{"key":"BFijo2013205_CR29","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1053\/j.gastro.2010.02.059","volume":"138","author":"MA Stefater","year":"2010","unstructured":"Stefater MA, Perez-Tilve D, Chambers AP, Wilson-Perez HE, Sandoval DA, Berger J et al. Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. Gastroenterology 2010; 138: 2426\u20132436 2436 e1-3.","journal-title":"Gastroenterology"},{"key":"BFijo2013205_CR30","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/ijo.2012.167","volume":"36","author":"N Saeidi","year":"2012","unstructured":"Saeidi N, Nestoridi E, Kucharczyk J, Uygun MK, Yarmush ML, Stylopoulos N . Sleeve gastrectomy and Roux-en-Y gastric bypass exhibit differential effects on food preferences, nutrient absorption and energy expenditure in obese rats. Int J Obes (Lond) 2012; 36: 1396\u20131402.","journal-title":"Int J Obes (Lond)"},{"issue":"Suppl 3","key":"BFijo2013205_CR31","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1038\/ijo.2011.144","volume":"35","author":"PR Burton","year":"2011","unstructured":"Burton PR, Brown WA . The mechanism of weight loss with laparoscopic adjustable gastric banding: induction of satiety not restriction. Int J Obes (Lond) 2011; 35 (Suppl 3): S26\u2013S30.","journal-title":"Int J Obes (Lond)"},{"key":"BFijo2013205_CR32","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1210\/jc.2004-1546","volume":"90","author":"AF Dixon","year":"2005","unstructured":"Dixon AF, Dixon JB, O'Brien PE . Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study. J Clin Endocrinol Metab 2005; 90: 813\u2013819.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2013205_CR33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11695-008-9769-3","volume":"19","author":"B Ernst","year":"2009","unstructured":"Ernst B, Thurnheer M, Wilms B, Schultes B . Differential changes in dietary habits after gastric bypass versus gastric banding operations. Obes Surg 2009; 19: 274\u2013280.","journal-title":"Obes Surg"},{"key":"BFijo2013205_CR34","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s11695-011-0375-4","volume":"21","author":"JP Valderas","year":"2011","unstructured":"Valderas JP, Irribarra V, Rubio L, Boza C, Escalona M, Liberona Y et al. Effects of sleeve gastrectomy and medical treatment for obesity on glucagon-like peptide 1 levels and glucose homeostasis in non-diabetic subjects. Obes Surg 2011; 21: 902\u2013909.","journal-title":"Obes Surg"},{"key":"BFijo2013205_CR35","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s11695-012-0624-1","volume":"22","author":"MS Dar","year":"2012","unstructured":"Dar MS, Chapman WH 3rd, Pender JR, Drake AJ 3rd, O'Brien K, Tanenberg RJ et al. GLP-1 response to a mixed meal: what happens 10 years after Roux-en-Y gastric bypass (RYGB)? Obes Surg 2012; 22: 1077\u20131083.","journal-title":"Obes Surg"},{"key":"BFijo2013205_CR36","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.soard.2009.11.019","volume":"6","author":"S Shah","year":"2010","unstructured":"Shah S, Shah P, Todkar J, Gagner M, Sonar S, Solav S . Prospective controlled study of effect of laparoscopic sleeve gastrectomy on small bowel transit time and gastric emptying half-time in morbidly obese patients with type 2 diabetes mellitus. Surg Obes Relat Dis 2010; 6: 152\u2013157.","journal-title":"Surg Obes Relat Dis"},{"key":"BFijo2013205_CR37","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ijo.2009.79","volume":"33","author":"J Korner","year":"2009","unstructured":"Korner J, Inabnet W, Febres G, Conwell IM, McMahon DJ, Salas R et al. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) 2009; 33: 786\u2013795.","journal-title":"Int J Obes (Lond)"},{"key":"BFijo2013205_CR38","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s00268-009-0080-9","volume":"33","author":"DJ Pournaras","year":"2009","unstructured":"Pournaras DJ, le Roux CW . Obesity, gut hormones, and bariatric surgery. World J Surg 2009; 33: 1983\u20131988.","journal-title":"World J Surg"},{"key":"BFijo2013205_CR39","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1381\/0960892054621125","volume":"15","author":"FB Langer","year":"2005","unstructured":"Langer FB, Reza Hoda MA, Bohdjalian A, Felberbauer FX, Zacherl J, Wenzl E et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 2005; 15: 1024\u20131029.","journal-title":"Obes Surg"},{"key":"BFijo2013205_CR40","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.2174\/13816128113198880010","volume":"19","author":"WJ Lee","year":"2013","unstructured":"Lee WJ, Chen CY, Ser KH, Chong K, Chen SC, Lee PC et al. Differential influences of gastric bypass and sleeve gastrectomy on plasma Nesfatin-1 and Obestatin levels in patients with type 2 diabetes mellitus. Curr Pharm Des 2013; 19: 5830\u20135835.","journal-title":"Curr Pharm Des"},{"key":"BFijo2013205_CR41","first-page":"178ra41","volume":"5","author":"AP Liou","year":"2013","unstructured":"Liou AP, Paziuk M, Luevano JM Jr., Machineni S, Turnbaugh PJ, Kaplan LM . Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med 2013; 5: 178ra41.","journal-title":"Sci Transl Med"},{"key":"BFijo2013205_CR42","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/01.sla.0000133117.12646.48","volume":"240","author":"F Rubino","year":"2004","unstructured":"Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 2004; 240: 236\u2013242.","journal-title":"Ann Surg"},{"key":"BFijo2013205_CR43","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1007\/s00464-011-1755-5","volume":"25","author":"N Basso","year":"2011","unstructured":"Basso N, Capoccia D, Rizzello M, Abbatini F, Mariani P, Maglio C et al. First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis. Surg Endosc 2011; 25: 3540\u20133550.","journal-title":"Surg Endosc"},{"key":"BFijo2013205_CR44","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ijo.2009.254","volume":"34","author":"SR Kashyap","year":"2010","unstructured":"Kashyap SR, Daud S, Kelly KR, Gastaldelli A, Win H, Brethauer S et al. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond) 2010; 34: 462\u2013471.","journal-title":"Int J Obes (Lond)"},{"key":"BFijo2013205_CR45","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1172\/JCI64895","volume":"122","author":"D Bradley","year":"2012","unstructured":"Bradley D, Conte C, Mittendorfer B, Eagon JC, Varela JE, Fabbrini E et al. Gastric bypass and banding equally improve insulin sensitivity and beta cell function. J Clin Invest 2012; 122: 4667\u20134674.","journal-title":"J Clin Invest"},{"key":"BFijo2013205_CR46","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.surg.2009.10.059","volume":"147","author":"WJ Lee","year":"2010","unstructured":"Lee WJ, Ser KH, Chong K, Lee YC, Chen SC, Tsou JJ et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. Surgery 2010; 147: 664\u2013669.","journal-title":"Surgery"},{"key":"BFijo2013205_CR47","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/SLA.0b013e3181ae32e3","volume":"250","author":"R Peterli","year":"2009","unstructured":"Peterli R, Wolnerhanssen B, Peters T, Devaux N, Kern B, Christoffel-Courtin C et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 2009; 250: 234\u2013241.","journal-title":"Ann Surg"},{"key":"BFijo2013205_CR48","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.2337\/db11-0203","volume":"60","author":"M Salehi","year":"2011","unstructured":"Salehi M, Prigeon RL, D'Alessio DA . Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans. Diabetes 2011; 60: 2308\u20132314.","journal-title":"Diabetes"},{"key":"BFijo2013205_CR49","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1007\/s00125-011-2204-7","volume":"54","author":"EL Lim","year":"2011","unstructured":"Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R . Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 2011; 54: 2506\u20132514.","journal-title":"Diabetologia"},{"key":"BFijo2013205_CR50","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/j.gastro.2012.07.114","volume":"143","author":"D Bradley","year":"2012","unstructured":"Bradley D, Magkos F, Klein S . Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology 2012; 143: 897\u2013912.","journal-title":"Gastroenterology"},{"key":"BFijo2013205_CR51","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/SLA.0b013e3181efc49a","volume":"252","author":"DJ Pournaras","year":"2010","unstructured":"Pournaras DJ, Osborne A, Hawkins SC, Vincent RP, Mahon D, Ewings P et al. Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg 2010; 252: 966\u2013971.","journal-title":"Ann Surg"},{"key":"BFijo2013205_CR52","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1007\/s11695-011-0527-6","volume":"21","author":"J Foo","year":"2011","unstructured":"Foo J, Krebs J, Hayes MT, Bell D, Macartney-Coxson D, Croft T et al. Studies in insulin resistance following very low calorie diet and\/or gastric bypass surgery. Obes Surg 2011; 21: 1914\u20131920.","journal-title":"Obes Surg"},{"key":"BFijo2013205_CR53","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cmet.2008.08.008","volume":"8","author":"S Troy","year":"2008","unstructured":"Troy S, Soty M, Ribeiro L, Laval L, Migrenne S, Fioramonti X et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab 2008; 8: 201\u2013211.","journal-title":"Cell Metab"},{"key":"BFijo2013205_CR54","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/nm.2745","volume":"18","author":"DM Breen","year":"2012","unstructured":"Breen DM, Rasmussen BA, Kokorovic A, Wang R, Cheung GW, Lam TK . Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. Nat Med 2012; 18: 950\u2013955.","journal-title":"Nat Med"},{"key":"BFijo2013205_CR55","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrd2619","volume":"7","author":"C Thomas","year":"2008","unstructured":"Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K . Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov 2008; 7: 678\u2013693.","journal-title":"Nat Rev Drug Discov"},{"key":"BFijo2013205_CR56","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1210\/en.2011-2145","volume":"153","author":"DJ Pournaras","year":"2012","unstructured":"Pournaras DJ, Glicksman C, Vincent RP, Kuganolipava S, Alaghband-Zadeh J, Mahon D et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 2012; 153: 3613\u20133619.","journal-title":"Endocrinology"},{"key":"BFijo2013205_CR57","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1053\/j.gastro.2011.05.008","volume":"141","author":"MA Stefater","year":"2011","unstructured":"Stefater MA, Sandoval DA, Chambers AP, Wilson-Perez HE, Hofmann SM, Jandacek R et al. Sleeve gastrectomy in rats improves postprandial lipid clearance by reducing intestinal triglyceride secretion. Gastroenterology 2011; 141: 939\u2013949 e1-4.","journal-title":"Gastroenterology"},{"key":"BFijo2013205_CR58","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1105816","volume":"365","author":"P Sumithran","year":"2011","unstructured":"Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med 2011; 365: 1597\u20131604.","journal-title":"N Engl J Med"},{"key":"BFijo2013205_CR59","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa1007137","volume":"363","author":"TM Larsen","year":"2010","unstructured":"Larsen TM, Dalskov SM, van Baak M, Jebb SA, Papadaki A, Pfeiffer AF et al. Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med 2010; 363: 2102\u20132113.","journal-title":"N Engl J Med"},{"key":"BFijo2013205_CR60","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/ajcn\/87.1.44","volume":"87","author":"AM Johnstone","year":"2008","unstructured":"Johnstone AM, Horgan GW, Murison SD, Bremner DM, Lobley GE . Effects of a high-protein ketogenic diet on hunger, appetite, and weight loss in obese men feeding ad libitum. Am J Clin Nutr 2008; 87: 44\u201355.","journal-title":"Am J Clin Nutr"},{"key":"BFijo2013205_CR61","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3945\/ajcn.112.042457","volume":"97","author":"O Ajala","year":"2013","unstructured":"Ajala O, English P, Pinkney J . Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr 2013; 97: 505\u2013516.","journal-title":"Am J Clin Nutr"},{"key":"BFijo2013205_CR62","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","volume":"368","author":"R Estruch","year":"2013","unstructured":"Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013; 368: 1279\u20131290.","journal-title":"N Engl J Med"},{"key":"BFijo2013205_CR63","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1001\/jama.2012.67929","volume":"308","author":"EW Gregg","year":"2012","unstructured":"Gregg EW, Chen H, Wagenknecht LE, Clark JM, Delahanty LM, Bantle J et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 2012; 308: 2489\u20132496.","journal-title":"JAMA"},{"key":"BFijo2013205_CR64","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","volume":"369","author":"RR Wing","year":"2013","unstructured":"Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013; 369: 145\u2013154.","journal-title":"N Engl J Med"},{"key":"BFijo2013205_CR65","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/157489008786264014","volume":"3","author":"A Samat","year":"2008","unstructured":"Samat A, Tomlinson B, Taheri S, Thomas GN . Rimonabant for the treatment of obesity. Recent Pat Cardiovasc Drug Discov 2008; 3: 187\u2013193.","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"key":"BFijo2013205_CR66","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMoa1003114","volume":"363","author":"WP James","year":"2010","unstructured":"James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med 2010; 363: 905\u2013917.","journal-title":"N Engl J Med"},{"key":"BFijo2013205_CR67","doi-asserted-by":"crossref","first-page":"532","DOI":"10.7326\/0003-4819-142-7-200504050-00012","volume":"142","author":"Z Li","year":"2005","unstructured":"Li Z, Maglione M, Tu W, Mojica W, Arterburn D, Shugarman LR et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med 2005; 142: 532\u2013546.","journal-title":"Ann Intern Med"},{"key":"BFijo2013205_CR68","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/diacare.27.1.155","volume":"27","author":"JS Torgerson","year":"2004","unstructured":"Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L . XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004; 27: 155\u2013161.","journal-title":"Diabetes Care"},{"key":"BFijo2013205_CR69","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJMoa0909809","volume":"363","author":"SR Smith","year":"2010","unstructured":"Smith SR, Weissman NJ, Anderson CM, Sanchez M, Chuang E, Stubbe S et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med 2010; 363: 245\u2013256.","journal-title":"N Engl J Med"},{"key":"BFijo2013205_CR70","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1210\/jc.2011-1256","volume":"96","author":"MC Fidler","year":"2011","unstructured":"Fidler MC, Sanchez M, Raether B, Weissman NJ, Smith SR, Shanahan WR et al. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial. J Clin Endocrinol Metab 2011; 96: 3067\u20133077.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2013205_CR71","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/oby.2012.66","volume":"20","author":"PM O'Neil","year":"2012","unstructured":"O'Neil PM, Smith SR, Weissman NJ, Fidler MC, Sanchez M, Zhang J et al. Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. Obesity (Silver Spring) 2012; 20: 1426\u20131436.","journal-title":"Obesity (Silver Spring)"},{"key":"BFijo2013205_CR72","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","volume":"377","author":"KM Gadde","year":"2011","unstructured":"Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet 2011; 377: 1341\u20131352.","journal-title":"Lancet"},{"key":"BFijo2013205_CR73","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3945\/ajcn.111.024927","volume":"95","author":"WT Garvey","year":"2012","unstructured":"Garvey WT, Ryan DH, Look M, Gadde KM, Allison DB, Peterson CA et al. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine\/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr 2012; 95: 297\u2013308.","journal-title":"Am J Clin Nutr"},{"key":"BFijo2013205_CR74","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/oby.2011.330","volume":"20","author":"DB Allison","year":"2012","unstructured":"Allison DB, Gadde KM, Garvey WT, Peterson CA, Schwiers ML, Najarian T et al. Controlled-release phentermine\/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring) 2012; 20: 330\u2013342.","journal-title":"Obesity (Silver Spring)"},{"key":"BFijo2013205_CR75","doi-asserted-by":"crossref","first-page":"E701","DOI":"10.1152\/ajpendo.00024.2003","volume":"285","author":"RL Prigeon","year":"2003","unstructured":"Prigeon RL, Quddusi S, Paty B, D'Alessio DA . Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect. Am J Physiol Endocrinol Metab 2003; 285: E701\u2013E707.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFijo2013205_CR76","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(08)61206-4","volume":"372","author":"DJ Drucker","year":"2008","unstructured":"Drucker DJ, Buse JB, Taylor K, Kendall DM, Trautmann M, Zhuang D et al. Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. Lancet 2008; 372: 1240\u20131250.","journal-title":"Lancet"},{"key":"BFijo2013205_CR77","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1210\/jc.2010-2081","volume":"96","author":"T Blevins","year":"2011","unstructured":"Blevins T, Pullman J, Malloy J, Yan P, Taylor K, Schulteis C et al. DURATION-5: exenatide once weekly resulted in greater improvements in glycemic control compared with exenatide twice daily in patients with type 2 diabetes. J Clin Endocrinol Metab 2011; 96: 1301\u20131310.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2013205_CR78","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(09)60659-0","volume":"374","author":"JB Buse","year":"2009","unstructured":"Buse JB, Rosenstock J, Sesti G, Schmidt WE, Montanya E, Brett JH et al. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet 2009; 374: 39\u201347.","journal-title":"Lancet"},{"key":"BFijo2013205_CR79","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/dc08-2124","volume":"32","author":"B Zinman","year":"2009","unstructured":"Zinman B, Gerich J, Buse JB, Lewin A, Schwartz S, Raskin P et al. Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD). Diabetes Care 2009; 32: 1224\u20131230.","journal-title":"Diabetes Care"},{"key":"BFijo2013205_CR80","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2337\/dc08-1797","volume":"32","author":"MC Bunck","year":"2009","unstructured":"Bunck MC, Diamant M, Corner A, Eliasson B, Malloy JL, Shaginian RM et al. One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial. Diabetes Care 2009; 32: 762\u2013768.","journal-title":"Diabetes Care"},{"key":"BFijo2013205_CR81","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1210\/jc.2010-2822","volume":"96","author":"JB Buse","year":"2011","unstructured":"Buse JB, Garber A, Rosenstock J, Schmidt WE, Brett JH, Videbaek N et al. Liraglutide treatment is associated with a low frequency and magnitude of antibody formation with no apparent impact on glycemic response or increased frequency of adverse events: results from the Liraglutide Effect and Action in Diabetes (LEAD) trials. J Clin Endocrinol Metab 2011; 96: 1695\u20131702.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2013205_CR82","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/dom.12121","volume":"15","author":"M Pinget","year":"2013","unstructured":"Pinget M, Goldenberg R, Niemoeller E, Muehlen-Bartmer I, Guo H, Aronson R . Efficacy and safety of lixisenatide once daily versus placebo in type 2 diabetes insufficiently controlled on pioglitazone (GetGoal-P). Diabetes Obes Metab 2013; 15: 1000\u20131007.","journal-title":"Diabetes Obes Metab"},{"key":"BFijo2013205_CR83","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.2337\/dc12-2454","volume":"36","author":"MC Riddle","year":"2013","unstructured":"Riddle MC, Aronson R, Home P, Marre M, Niemoeller E, Miossec P et al. Adding once-daily Lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L). Diabetes Care 2013; 36: 2489\u20132496.","journal-title":"Diabetes Care"},{"key":"BFijo2013205_CR84","doi-asserted-by":"crossref","first-page":"d7771","DOI":"10.1136\/bmj.d7771","volume":"344","author":"T Vilsboll","year":"2012","unstructured":"Vilsboll T, Christensen M, Junker AE, Knop FK, Gluud LL . Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials. BMJ 2012; 344: d7771.","journal-title":"BMJ"},{"key":"BFijo2013205_CR85","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2265.2012.04483.x","volume":"77","author":"D Russell-Jones","year":"2012","unstructured":"Russell-Jones D, Gough S . Recent advances in incretin-based therapies. Clin Endocrinol (Oxf) 2012; 77: 489\u2013499.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFijo2013205_CR86","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1210\/en.2011-0286","volume":"152","author":"A Waget","year":"2011","unstructured":"Waget A, Cabou C, Masseboeuf M, Cattan P, Armanet M, Karaca M et al. Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice. Endocrinology 2011; 152: 3018\u20133029.","journal-title":"Endocrinology"},{"key":"BFijo2013205_CR87","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1210\/jc.2012-1205","volume":"97","author":"E Muscelli","year":"2012","unstructured":"Muscelli E, Casolaro A, Gastaldelli A, Mari A, Seghieri G, Astiarraga B et al. Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes. J Clin Endocrinol Metab 2012; 97: 2818\u20132826.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2013205_CR88","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1517\/14656566.2011.581663","volume":"12","author":"LM Younk","year":"2011","unstructured":"Younk LM, Mikeladze M, Davis SN . Pramlintide and the treatment of diabetes: a review of the data since its introduction. Expert Opin Pharmacother 2011; 12: 1439\u20131451.","journal-title":"Expert Opin Pharmacother"},{"key":"BFijo2013205_CR89","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1345\/aph.1Q538","volume":"46","author":"SL Anderson","year":"2012","unstructured":"Anderson SL, Marrs JC . Dapagliflozin for the treatment of type 2 diabetes. Ann Pharmacother 2012; 46: 590\u2013598.","journal-title":"Ann Pharmacother"},{"key":"BFijo2013205_CR90","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/SLA.0b013e3181bdfbff","volume":"251","author":"R Schouten","year":"2010","unstructured":"Schouten R, Rijs CS, Bouvy ND, Hameeteman W, Koek GH, Janssen IM et al. A multicenter, randomized efficacy study of the endobarrier gastrointestinal liner for presurgical weight loss prior to bariatric surgery. Ann Surg 2010; 251: 236\u2013243.","journal-title":"Ann Surg"},{"key":"BFijo2013205_CR91","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.gie.2009.11.051","volume":"71","author":"KS Gersin","year":"2010","unstructured":"Gersin KS, Rothstein RI, Rosenthal RJ, Stefanidis D, Deal SE, Kuwada TS et al. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc 2010; 71: 976\u2013982.","journal-title":"Gastrointest Endosc"},{"key":"BFijo2013205_CR92","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/dia.2011.0152","volume":"14","author":"EG de Moura","year":"2012","unstructured":"de Moura EG, Martins BC, Lopes GS, Orso IR, de Oliveira SL, Galvao Neto MP et al. Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner. Diabetes Technol Ther 2012; 14: 183\u2013189.","journal-title":"Diabetes Technol Ther"},{"key":"BFijo2013205_CR93","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1097\/SLA.0b013e31825498c4","volume":"255","author":"A Escalona","year":"2012","unstructured":"Escalona A, Pimentel F, Sharp A, Becerra P, Slako M, Turiel D et al. Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner. Ann Surg 2012; 255: 1080\u20131085.","journal-title":"Ann Surg"},{"key":"BFijo2013205_CR94","doi-asserted-by":"crossref","first-page":"E279","DOI":"10.1210\/jc.2012-2814","volume":"98","author":"RV Cohen","year":"2013","unstructured":"Cohen RV, Neto MG, Correa JL, Sakai P, Martins B, Schiavon CA et al. A pilot study of the duodenal-jejunal bypass liner in low body mass index type 2 diabetes. J Clin Endocrinol Metab 2013; 98: E279\u2013E282.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2013205_CR95","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.3748\/wjg.v18.i19.2309","volume":"18","author":"M Mizrahi","year":"2012","unstructured":"Mizrahi M, Ben Ya'acov A, Ilan Y . Gastric stimulation for weight loss. World J Gastroenterol 2012; 18: 2309\u20132319.","journal-title":"World J Gastroenterol"},{"key":"BFijo2013205_CR96","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.soard.2008.09.012","volume":"5","author":"SA Shikora","year":"2009","unstructured":"Shikora SA, Bergenstal R, Bessler M, Brody F, Foster G, Frank A et al. Implantable gastric stimulation for the treatment of clinically severe obesity: results of the SHAPE trial. Surg Obes Relat Dis 2009; 5: 31\u201337.","journal-title":"Surg Obes Relat Dis"},{"key":"BFijo2013205_CR97","doi-asserted-by":"crossref","unstructured":"Fernandes M, Atallah AN, Soares BG, Humberto S, Guimaraes S, Matos D et al. Intragastric balloon for obesity. Cochrane Database Syst Rev 2007; CD004931.","DOI":"10.1002\/14651858.CD004931.pub2"},{"key":"BFijo2013205_CR98","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1056\/NEJMoa1112082","volume":"367","author":"LM Carlsson","year":"2012","unstructured":"Carlsson LM, Peltonen M, Ahlin S, Anveden A, Bouchard C, Carlsson B et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med 2012; 367: 695\u2013704.","journal-title":"N Engl J Med"},{"key":"BFijo2013205_CR99","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1056\/NEJMoa035622","volume":"351","author":"L Sjostrom","year":"2004","unstructured":"Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683\u20132693.","journal-title":"N Engl J Med"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ijo2013205.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ijo2013205","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ijo2013205.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:28:59Z","timestamp":1684430939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ijo2013205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,11]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["BFijo2013205"],"URL":"https:\/\/doi.org\/10.1038\/ijo.2013.205","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,11]]}}}